[PDF][PDF] Efficacy of Molnupiravir for the treatment of mild or moderate COVID-19 in adults: a meta-analysis

K Benaicha, RR Khenhrani, M Veer, S Devi… - Cureus, 2023 - cureus.com
The aim of this meta-analysis is to evaluate the efficacy of molnupiravir among mild or
moderate COVID-19 patients. This meta-analysis was reported according to the guidelines …

[HTML][HTML] Real-world clinical outcomes of molnupiravir for the treatment of mild to moderate COVID-19 in adult patients during the dominance of the omicron variant: A …

C Huang, TL Lu, L Lin - Antibiotics, 2023 - mdpi.com
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …

[HTML][HTML] Effectiveness, tolerability and prescribing choice of antiviral molecules molnupiravir, remdesivir and nirmatrelvir/r: a real-world comparison in the first ten …

C Del Borgo, S Garattini, C Bortignon, A Carraro… - Viruses, 2023 - mdpi.com
In 2022, three antiviral drugs—molnupiravir, remdesivir and nirmatrelvir/ritonavir—were
introduced for treatment of mild-to-moderate COVID-19 in high-risk patients. The aim of this …

[HTML][HTML] Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system

Y Liang, L Ma, Y Wang, J Zheng, L Su… - Frontiers in …, 2023 - frontiersin.org
Molnupiravir, an urgently approved drug during the Coronavirus Disease 2019 (COVID-19)
pandemic, serves as the basis for our study, which relies on the Food and Drug …

[HTML][HTML] New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human …

AE Siniavin, VA Gushchin, SS Natal'ya, ES Darnotuk… - Antiviral Research, 2024 - Elsevier
The spread of COVID-19 continues due to genetic variation in SARS-CoV-2. Highly mutated
variants of SARS-CoV-2 have an increased transmissibility and immune evasion. Due to the …

[HTML][HTML] Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population

B Herman, MCS Wong, P Chantharit, FF Hannanu… - Scientific Reports, 2023 - nature.com
The COVID-19 infection is assumed to induce cognitive failure. Identifying the relationship
between COVID-19, the effect of vaccination and medication, and accommodating non …

[HTML][HTML] Molecular Epidemiology of SARS-CoV-2 Omicron Sub-Lineages Isolated from Turkish Patients Infected with COVID-19

M Sayan, A Arikan, E Sanlidag - Viruses, 2023 - mdpi.com
Early detection and characterization of new variants and their impacts enable improved
genomic surveillance. This study aims to evaluate the subvariant distribution of Omicron …

Experimental and theoretical study on supramolecular encapsulation of molnupiravir by Cucurbit [7] uril: A potential formulating agent for COVID-19

S Sen, N Baildya, M Alphonse-Mendoza… - Journal of Molecular …, 2024 - Elsevier
Global propagation of the Novel Coronavirus Diseases-2019 (COVID-19) outbreak
threatens the scientific community's ability to develop and learn effective SARS-CoV-2 …

Adverse drug reactions associated with COVID-19 management

V Chavda, P Dodiya, V Apostolopoulos - … -Schmiedeberg's Archives of …, 2024 - Springer
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
outbreak, which causes COVID-19, had a devastating impact on both people's lives and the …

[HTML][HTML] Antiviral properties of milk proteins and peptides against SARS-COV-2: A review

P Singh, J Dhakal, P Kumar - Journal of Functional Foods, 2024 - Elsevier
Certain milk proteins and peptides exhibit promising immunogenic and antiviral properties,
particularly against coronaviruses like SARS-CoV-2. Amidst the global pandemic, these …